Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.
Brain metastases are difficult to treat and mostly develop late during progressive metastatic disease. Patients at risk would benefit from the development of prevention and improved treatments. This requires knowledge of the initial events that lead to brain metastasis. The present study reveals cellular events during the initiation of brain metastasis by breast cancer cells and documents the earliest host responses to incoming cancer cells after carotid artery injection in immunodeficient and immunocompetent mouse models. Our findings capture and characterize heterogeneous astrocytic and microglial reactions to the arrest and extravasation of cancer cells in the brain, showing immediate and drastic changes in the brain microenvironment on arrival of individual cancer cells. We identified reactive astrocytes as the most active host cell population that immediately localizes to individual invading tumor cells and continuously associates with growing metastatic lesions. Up-regulation of matrix metalloproteinase-9 associated with astrocyte activation in the immediate vicinity of extravasating cancer cells might support their progression. Early involvement of different host cell types indicates environmental clues that might codetermine whether a single cancer cell progresses to macrometastasis or remains dormant. Thus, information on the initial interplay between brain homing tumor cells and reactive host cells may help develop strategies for prevention and treatment of symptomatic breast cancer brain metastases.
Lorger
Mihaela
M
Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, MEM-150, La Jolla, CA 92037, USA. mlorger@scripps.edu
Felding-Habermann
Brunhilde
B
D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D001808:Blood Vessels / Q000378:metabolism / Q000473:pathology; D001921:Brain / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology*; D001932:Brain Neoplasms / Q000098:blood supply / Q000378:metabolism / Q000473:pathology*; D001943:Breast Neoplasms / Q000098:blood supply / Q000378:metabolism / Q000556:secondary*; D045744:Cell Line, Tumor; D002560:Cerebrovascular Circulation; D018450:Disease Progression; D005260:Female; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D017628:Microglia / Q000378:metabolism; D009362:Neoplasm Metastasis
J Neurosci. 2004 Mar 3;24(9):2133-42
14999064
Cancer Metastasis Rev. 1995 Dec;14(4):279-301
8821091
Int J Cancer. 1997 Jan 17;70(2):169-74
9009156
Curr Top Dev Biol. 2005;69:67-99
16243597
Clin Exp Metastasis. 2000;18(6):481-92
11592305
Nature. 2009 Jun 18;459(7249):1005-9
19421193
Clin Exp Pharmacol Physiol. 2007 Jul;34(7):624-31
17581219
J Neurooncol. 1997 Oct;35(1):81-9
9266444
Curr Top Microbiol Immunol. 1996;213 ( Pt 2):89-115
9053298
Brain Res. 2002 Feb 15;927(2):153-67
11821009
Neurotox Res. 2010 Jan;17(1):50-65
19554388
Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12530-5
19617536
Clin Exp Metastasis. 2008;25(7):799-810
18649117
Int J Cancer. 2007 Mar 1;120(5):1023-6
17187362
Clin Exp Metastasis. 1983 Jul-Sep;1(3):247-59
6546202
J Neuropathol Exp Neurol. 2005 Sep;64(9):754-62
16141784
Cancer Metastasis Rev. 1999;18(3):387-400
10721492
Int J Oncol. 2009 Oct;35(4):665-72
19724901
Toxicol Lett. 2003 Apr 4;139(2-3):181-9
12628753
Mol Med. 2006 Jul-Aug;12(7-8):161-70
17088948
Cancer Cell. 2008 Mar;13(3):206-20
18328425
Cancer Res. 2009 Feb 1;69(3):828-35
19141644
J Cell Biochem. 2004 Jan 1;91(1):206-15
14689592
Cancer Res. 2000 Sep 1;60(17):4767-70
10987284
Genes Dev. 2007 Dec 15;21(24):3258-71
18079173
Invasion Metastasis. 1982;2(1):40-50
7188390
J Natl Cancer Inst. 2007 Nov 7;99(21):1583-93
17971532
Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10666-71
19541645
Nat Med. 2000 Jan;6(1):100-2
10613833
Neoplasma. 2009;56(4):284-90
19473053
Neuroreport. 2005 Oct 17;16(15):1687-91
16189478
Cancer Cell. 2007 Jan;11(1):69-82
17222791
Acta Neuropathol. 1996 Sep;92(3):288-93
8870831
Glia. 1997 Jan;19(1):13-26
8989564
Glia. 2006 Nov 1;54(6):619-29
16944452
Brain Res. 1993 Oct 22;625(2):238-43
7903899
J Neuropathol Exp Neurol. 1979 Jan;38(1):19-34
430105
Curr Oncol Rep. 2001 Nov;3(6):467-75
11595114
Lab Invest. 1997 Oct;77(4):357-68
9354770
Magn Reson Med. 2006 Nov;56(5):1001-10
17029229
Nat Rev Cancer. 2009 Apr;9(4):239-52
19279573
Stem Cells. 2007 Nov;25(11):2777-85
17641243
J Neurooncol. 2006 Dec;80(3):227-33
16826367
Neuroscientist. 2005 Oct;11(5):400-7
16151042
Cancer Res. 2009 Jul 1;69(13):5292-3
19549886
J Surg Res. 1999 Jan;81(1):42-7
9889056
Nat Rev Cancer. 2007 Feb;7(2):139-47
17218951
Stem Cells Dev. 2008 Oct;17(5):859-67
18429673
Hum Mol Genet. 2007 May 1;16(9):1098-112
17400655
Neurosurg Focus. 2007 Mar 15;22(3):E1
17608351
Cancer Res. 2009 Oct 1;69(19):7893
19723654
Clin Exp Metastasis. 2009;26(5):403-14
19277878
Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8384-9
15155908
Prog Brain Res. 2000;127:1-11
11142024
PLoS One. 2009 Jun 10;4(6):e5857
19516901
Adv Cancer Res. 2000;79:91-121
10818678
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3581-6
18299565
Am J Pathol. 1998 Sep;153(3):865-73
9736035
Cancer Res. 2001 Aug 1;61(15):5736-40
11479209
Brain Res Bull. 1994;34(1):73-8
8193937
Histochem Cell Biol. 2008 Dec;130(6):1119-30
19005674
J Bone Miner Res. 2001 Aug;16(8):1486-95
11499871
J Neurooncol. 2009 May;92(3):275-82
19357955
Mol Cell Neurosci. 2008 Jun;38(2):170-82
18434192
Cancer Res. 1999 Mar 15;59(6):1295-300
10096562
Trends Neurosci. 1990 Feb;13(2):43-6
1690928
J Natl Cancer Inst. 1992 May 20;84(10):797-803
1573668
Cell Cycle. 2009 Jun 1;8(11):1654-8
19448435